Switching Between GLP-1 Treatments: What You Need To Know
Can You Switch From Wegovy To Mounjaro: Understanding The Key Differences
When considering whether you can switch from Wegovy to Mounjaro, it's essential to understand that these are fundamentally different medications with distinct mechanisms of action. Wegovy contains semaglutide, which targets GLP-1 receptors exclusively, whilst Mounjaro contains tirzepatide, a dual-acting medication that targets both GIP and GLP-1 receptors simultaneously. This difference in mechanism means that switching between these treatments requires careful medical supervision and potentially different dosing strategies. Your prescriber will need to assess your current response to Wegovy, any side effects experienced, and your individual treatment goals before determining if switching to Mounjaro is appropriate for your circumstances.
The decision to switch from Wegovy to Mounjaro often depends on factors such as treatment response, tolerability, and practical considerations like storage requirements. Both medications are prescription-only medicines that require ongoing clinical monitoring, but they have different dose escalation schedules and maximum doses. Wegovy follows a 5-step escalation from 0.25mg to 2.4mg maintenance dose, whilst Mounjaro uses a 6-step progression from 2.5mg up to 15mg. EverydayMeds stocks both treatments, allowing your prescriber to recommend the most suitable option based on your medical history and treatment response, ensuring continuity of care when you can switch from Wegovy to Mounjaro if clinically appropriate.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding the cost implications when considering whether you can switch from Wegovy to Mounjaro is crucial for treatment planning. Wegovy pricing starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. Our Getting Started bundles offer convenient two-pen combinations, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. New customers benefit from the FIRST40 discount code, whilst returning patients use DOSE25, both applied at checkout to reach these final prices.
Mounjaro pricing follows a different structure reflecting its unique dosing schedule, with costs varying across the six available strengths from 2.5mg through to 15mg maximum dose. When evaluating whether you can switch from Wegovy to Mounjaro, consider that the medications have different maintenance dose requirements, which affects long-term treatment costs. Both treatments are available through the same streamlined ordering process at EverydayMeds, ensuring consistent access to cold-chain storage and next-day delivery regardless of which medication your prescriber recommends. The convenience of accessing both treatments through one GPhC-registered pharmacy (#9012878) simplifies the switching process if your clinical team determines this is appropriate.
Clinical Evidence: STEP Trials vs SURMOUNT Studies
The clinical evidence supporting both treatments comes from different trial programmes, making direct comparison complex when patients ask if they can switch from Wegovy to Mounjaro. Wegovy's efficacy is demonstrated through the STEP trial programme, where patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo. The STEP 5 trial showed sustained weight loss of approximately 15.2% at two years, whilst the recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events.
Mounjaro's evidence comes from the SURMOUNT trial series, which used different methodologies, patient populations, and endpoints, making head-to-head percentage comparisons inappropriate. Both medications have demonstrated significant efficacy in their respective clinical programmes, but individual response varies considerably between patients. When considering whether you can switch from Wegovy to Mounjaro, your prescriber will evaluate your personal response to treatment rather than comparing trial statistics, as real-world effectiveness depends on individual factors including genetics, lifestyle adherence, and concurrent medical conditions.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a naturally occurring hormone released by the intestines in response to food intake. This mechanism works by binding to GLP-1 receptors in the brain, particularly in areas that control appetite and food intake, leading to reduced hunger and increased feelings of satiety after smaller meals. The medication also slows gastric emptying, meaning food remains in the stomach longer, contributing to prolonged fullness between meals. Additionally, Wegovy may help reduce food cravings by influencing reward pathways in the brain associated with food-seeking behaviour. Understanding this mechanism is important when considering whether you can switch from Wegovy to Mounjaro, as Mounjaro's dual GIP/GLP-1 action represents a different pharmacological approach. The weekly injection schedule allows for consistent hormone level maintenance, supporting sustained appetite regulation throughout the treatment period.
Ordering Process: From Assessment To Delivery
Whether you're starting Wegovy or considering if you can switch from Wegovy to Mounjaro, EverydayMeds provides a streamlined ordering process beginning with a comprehensive 3-minute online clinical assessment. This assessment captures your medical history, current medications, weight management goals, and any previous experience with GLP-1 treatments, allowing prescribers to make informed recommendations about treatment selection. Following submission, our clinical team conducts a thorough review, with standard processing taking 3 working days or express review available within 24 hours for urgent requirements. Once approved, medications are dispatched via next-day delivery using specialised cold-chain packaging to maintain the 2-8°C storage requirements throughout transit. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet UK regulatory standards, whilst our clinical team remains available for ongoing support throughout your treatment journey. The same process applies whether you're beginning treatment or switching between medications under prescriber guidance.
Storage And Practical Considerations
Storage requirements present a key practical difference when patients can switch from Wegovy to Mounjaro, with implications for travel and daily management. Wegovy pens must be stored in the refrigerator at 2-8°C before first use but offer exceptional flexibility once removed, maintaining stability for up to 6 weeks at room temperature below 30°C. This extended room temperature stability makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules, compared to Mounjaro's 21-day room temperature limit. Both medications use pre-filled injection pens designed for ease of use, with Wegovy utilising Novo Nordisk's FlexTouch pen technology for consistent, comfortable injections. The dose escalation schedule requires careful planning, with Wegovy's 4-week intervals at each dose level allowing gradual tolerance development and side effect minimisation. Understanding these practical differences helps inform decisions about whether you can switch from Wegovy to Mounjaro based on lifestyle factors alongside clinical considerations. Proper storage and handling ensure medication effectiveness throughout the treatment period.
Switching Considerations: Medical Supervision Requirements
The question of whether you can switch from Wegovy to Mounjaro requires careful medical evaluation, as these medications have different pharmacokinetics, dose escalation schedules, and potentially different side effect profiles. Your prescriber will consider factors including your current Wegovy dose, treatment duration, weight loss response, side effect tolerance, and any concurrent medical conditions before recommending a switch. The transition typically requires stopping Wegovy and beginning Mounjaro at its initial 2.5mg dose, rather than attempting dose equivalency between the medications, as they work through different receptor mechanisms.
Timing considerations are crucial when patients can switch from Wegovy to Mounjaro, as the washout period between treatments and restart protocol must be carefully managed to minimise treatment disruption. Some patients may experience temporary changes in appetite control during the transition period, making dietary adherence particularly important. EverydayMeds' clinical team coordinates closely with prescribers to ensure smooth transitions, providing both medications through the same pharmacy system to maintain consistent cold-chain storage and delivery schedules. This integrated approach simplifies the switching process whilst ensuring continuous access to prescription-only weight management treatment under appropriate medical supervision.
Treatment Selection: Making The Right Choice For You
Ultimately, the decision about whether you can switch from Wegovy to Mounjaro depends on individual clinical factors that your healthcare provider is best positioned to evaluate. Both treatments are available through EverydayMeds, ensuring you have access to whichever medication your prescriber determines most appropriate for your circumstances. The choice between Wegovy's single GLP-1 mechanism and Mounjaro's dual GIP/GLP-1 action should be based on your treatment history, response patterns, lifestyle requirements, and clinical goals rather than attempting to determine which is universally "better". Our clinical assessment process captures the detailed information prescribers need to make these individualised recommendations, whether you're beginning treatment or considering a switch between medications. With both options available from the same trusted source, including express prescriber review and next-day delivery, you can focus on achieving your weight management goals with confidence. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment, using code FIRST40 for new customers or DOSE25 for returning patients, applied automatically at checkout to access these prescription-only medicines through our comprehensive weight management support programme.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
